Annie Wong‐Beringer

Therapeutic monitoring of vancomycin for serious methicillin-resistant <i>Staphylococcus aureus</i> infections: A revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists

Michael J. Rybak, Jennifer Lê, Thomas P. Lodise et al. · American Journal of Health-System Pharmacy · 2020 · 1K citations · Full text

High-Dose Vancomycin Therapy for Methicillin-Resistant Staphylococcus aureus Infections

Levita Hidayat, Donald Hsu, Ryan Quist et al. · Archives of Internal Medicine · 2006 · 848 citations

Therapeutic Monitoring of Vancomycin for Serious Methicillin-resistant Staphylococcus aureus Infections: A Revised Consensus Guideline and Review by the American Society of Health-system Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists

Michael J. Rybak, Jennifer Lê, Thomas P. Lodise et al. · Clinical Infectious Diseases · 2020 · 391 citations · Full text

Regulatory Oversight and Safety of Probiotic Use

Veena Venugopalan, Kimberly Shriner, Annie Wong‐Beringer · Emerging infectious diseases · 2010 · 210 citations · Full text

Dietary Supplements, Probiotic, Regulatory Oversight +13

Comparison of method-specific vancomycin minimum inhibitory concentration values and their predictability for treatment outcome of meticillin-resistant Staphylococcus aureus (MRSA) infections

Donald Hsu, Levita Hidayat, Ryan Quist et al. · International Journal of Antimicrobial Agents · 2008 · 173 citations

Treatment Outcome, Meticillin-resistant Staphylococcus Aureus, Health Sciences +10